CanSino’s inhaled booster vaccine stronger against Omicron BA.1 subvariant than Sinovac

Inhalation-based vaccine candidate elicits better antibody response than leading Chinese jab when used as a booster against BA.1, according to paper published without peer review.

Read the original article at South China Morning Post